Caseware UK (AP4) 2024.0.164 2024.0.164 falseThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.2024-02-01No description of principal activityfalsefalse22true 11776781 2025-01-31 11776781 c:Director1 2024-02-01 2025-01-31 11776781 2024-02-01 2025-01-31 11776781 2023-02-01 2024-01-31 11776781 2024-01-31 11776781 2024-02-01 11776781 2023-02-01 11776781 d:CurrentFinancialInstruments 2025-01-31 11776781 d:CurrentFinancialInstruments 2024-01-31 11776781 d:CurrentFinancialInstruments d:WithinOneYear 2025-01-31 11776781 d:CurrentFinancialInstruments d:WithinOneYear 2024-01-31 11776781 d:ShareCapital 2025-01-31 11776781 d:ShareCapital 2024-01-31 11776781 d:RetainedEarningsAccumulatedLosses 2025-01-31 11776781 d:RetainedEarningsAccumulatedLosses 2024-01-31 11776781 c:FRS102 2024-02-01 2025-01-31 11776781 c:AuditExempt-NoAccountantsReport 2024-02-01 2025-01-31 11776781 c:FullAccounts 2024-02-01 2025-01-31 11776781 c:PrivateLimitedCompanyLtd 2024-02-01 2025-01-31 11776781 2 2024-02-01 2025-01-31 11776781 e:PoundSterling 2024-02-01 2025-01-31 iso4217:GBP xbrli:pure
Company registration number: 11776781











ASIC HEALTH LIMITED
Unaudited
Financial statements
Information for filing with the registrar
For the Year Ended 31 January 2025

















Coveney Nicholls Limited
Chartered Accountants
The Old Wheel House
31/37 Church Street
Reigate
Surrey
UK
RH2 0AD

 
ASIC HEALTH LIMITED
Registered number:11776781

Statement of Financial Position
As at 31 January 2025

2025
2024
Note
£
£

  

Current assets
  

Debtors: amounts falling due within one year
 4 
8,654
11,873

Cash at bank and in hand
 5 
3,786
339

  
12,440
12,212

Creditors: amounts falling due within one year
 6 
(11,893)
(11,139)

Net current assets
  
 
 
547
 
 
1,073

Total assets less current liabilities
  
547
1,073

  

Net assets
  
547
1,073


Capital and reserves
  

Called up share capital 
  
100
100

Profit and loss account
  
447
973

  
547
1,073


The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 14 July 2025.




___________________________
Victoria Sweeney
Director

The notes on pages 3 to 5 form part of these financial statements.
Page 1

 
ASIC HEALTH LIMITED
Registered number:11776781
    
Statement of Financial Position (continued)
As at 31 January 2025


Page 2

 
ASIC HEALTH LIMITED
 
 
Notes to the Financial Statements

For the Year Ended 31 January 2025

1.


General information

The company is a private company limited by shares, registered in England and Wales. The
address of the registered office is The Old Wheel House, 31-37 Church Street, Reigate, Surrey,
RH2 0AD.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.3

Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
2.4

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

Page 3

 
ASIC HEALTH LIMITED
 
 
Notes to the Financial Statements

For the Year Ended 31 January 2025

2.Accounting policies (continued)

 
2.5

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the Company operates and generates income.


 
2.6

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.7

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.8

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.9

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.


3.


Employees




The average monthly number of employees, including directors, during the year was 2 (2024 - 2).


4.


Debtors

2025
2024
£
£


Trade debtors
5,343
2,000

Other debtors
3,311
9,873

8,654
11,873
Page 4

 
ASIC HEALTH LIMITED
 
 
Notes to the Financial Statements

For the Year Ended 31 January 2025

4.Debtors (continued)




5.


Cash and cash equivalents

2025
2024
£
£

Cash at bank and in hand
3,786
339

3,786
339



6.


Creditors: Amounts falling due within one year

2025
2024
£
£

Corporation tax
9,493
9,459

Accruals and deferred income
2,400
1,680

11,893
11,139



7.
Director's advances, credits and guarantees


2025

Balance brought forward
Advances/(credits) to the directors
Amounts repaid
Balance outstanding

£
£
£
£

Victoria Sweeney
9,873
39,931
(46,493)
3,311

2024

Balance brought forward
Advances/(credits) to the directors
Amounts repaid
Balance outstanding

£
£
£
£

Victoria Sweeney
5,270
48,325
(43,722)
9,873

The balance was repaid shortly after the year end. Interest at a rate of 2.5% is charged on overdrawn balances. 


 
Page 5